CytoDyn Archives | the deep dive

the deep dive

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations to create quality stock analysis for investors. Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

CytoDyn

Former Cytodyn Execs Charged With Fraud For Misrepresenting HIV, COVID Trials

CytoDyn Is Ready To Welcome Back The Former Chief Medical Officer It Terminated

FDA Puts CytoDyn Clinical Trials For HIV, COVID-19 On Hold

CytoDyn Begins Phase 3 Trial Of Antibody Treatment For Critically Ill COVID-19 Patients

CytoDyn Files Legal Actions Against Its Former Contract Research Organization

CytoDyn Starts Phase 3 Trial Of Antibody Treatment For COVID-19 Patients With Severe Symptoms In Brazil

Three Things to Know About ‘Phase 3 COVID Player’: Revive Therapeutics

Goliath Resources Hits 10.60 g/t Gold Over 22.82 Metres, Highest Grade Results In Third Distinct Rock Package At Surebet Discovery

Four Countries Control the Fertilizer That Feeds the World | Sage Potash

$10,000 Gold Is Just A Question of Time | Florian Grummes

ESGold Outlines $24.3 Million NPV For Tailings Reprocessing Project

First Majestic Encounters 711 g/t Silver Equivalent Over 8.0 Metres In Ongoing Exploration At Los Gatos